Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
Rev. Assoc. Med. Bras. (1992)
;
67(1): 26-28, Jan. 2021. graf
Article
in English
| LILACS
| ID: biblio-1287782
ABSTRACT
SUMMARY The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcranial Direct Current Stimulation (tDCS) is a non-pharmacological tool that could be associated with pharmacological treatments to improve the central nervous system function and decrease the exacerbation of the immune system response. tDCS targeting pain and fatigue-related areas could provide an increase in neuroplasticity and enhancements in physical functions. Moreover, it can be used in infirmaries and clinical centers to treat COVID-19 patients.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Transcranial Direct Current Stimulation
/
COVID-19
Type of study:
Etiology study
Limits:
Humans
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
UniversidadeFederal da Paraíba/BR
Similar
MEDLINE
...
LILACS
LIS